Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters

Transplantation Proceedings

Volumn 41, Issue 10, 2009, Pages 4181-4183

  Seymen, P ^a   Yildiz, M ^b   Turkmen M F ^a   Titiz, M I ^a   Seymen, H O ^c  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Kartal Ko uyolu Yüksek Ihtisas Educational and Research Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CREATININE; CYCLOSPORIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; LIPOPROTEIN A1; LIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CYCLOSPORINE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; LIPOPROTEIN(A); LIPOPROTEINS, HDL; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 71249139075     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.09.069     Document Type: Article

References (17)

1. Donald E.H. Hyperlipidemia in renal transplant recipients. Graft 3 (2000) 177
2. Vathsala A., Weinberg R.B., Schoenberg L., et al. Lipid abnormalities in cyclosporin-prednisone-treated renal transplant recipients. Transplantation 48 (1989) 37
3. Spinelli G.A., Felipe C.R., Machado P.G., et al. Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation. Braz J Med Biol Res 39 (2006) 19
4. Kasiske B.L., and Umen A.J. Persistent hyperlipidemia in renal transplant recipients. Medicine 66 (1987) 309
5. Baid Aqraval S., Delmonico F.L., Tolkoff-Rubin N.E., et al. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation 77 (2004) 1199
6. Liu J., Farmer J., Lane W., et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807
7. Yang H.C. Tailoring tacrolimus-based immunotherapy in renal transplantation. Nephrol Dial Transplant 18 (2003) i16
8. In: Grobbee D.E., and Lip G.Y.H. (Eds). Risk factor management in coronary artery disease (2003), Elsevier Limited, Spain 42
9. Stampfer M.J., Sacks F.M., Salvini S., et al. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 325 (1991) 373
10. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113 (1987) 589
11. Marcén R., Chahin J., Alarcón A., et al. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. Transplant Proc 38 (2006) 2427
12. Robinson D., Ferns G.A., Bevan E.A., et al. High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis 7 (1987) 341
13. Ballantyne F., Clark R.S., Simpson H.S., et al. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 31 (1982) 433
14. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042
15. Eikelboom J.W., Lonn E., Genest J., et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 363
16. Nygard O., Nordrehaug J.E., Refsum H., et al. Plasma homocysteine concentrations and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230
17. Jurewicz W.A. Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation. Nephrol Dial Transplant 18 (2003) i7